We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > eTheRNA

News List

eTheRNA immunotherapies joins forces with Ghent University europeanpharmaceuticalreview
July 26, 2021
eTheRNA has announced a collaboration and license agreement with renowned Belgian research institution, Ghent University.
Partnership to revolutionise RNA production europeanpharmaceuticalreview
July 01, 2021
Under a strategic collaboration eTheRNA immunotherapies and Quantoom Biosciences will develop a novel, scalable RNA production system.
ConserV Bio partners with eTheRNA on mRNA vaccine development pharmatimes
March 05, 2021
London, UK-based ConserV Bioscience has teamed up with eTheRNA immunotherapies to develop mRNA-based vaccines for infectious diseases.
eTheRNA Extends mRNA Production Services contractpharma
November 05, 2020
In response to growing international demand, eTheRNA has extended its mRNA production services to include high throughput research grade mRNA in addition to its GMP capabilities.